StonvexLoading…
StonvexCore line items from SCYX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-11 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $20.60M | $1.96M | $1.62M |
Operating Income | Not available | $-16.94M | $-16.07M | $-26.59M | $-18.19M |
Net Income | Not available | $-21.30M | $-8.61M | $-20.87M | $-12.28M |
EPS (Diluted) | $-0.09 | $-0.42 | $-0.17 | $-0.42 | $-0.25 |
Total Assets | Not available | $77.63M | $59.03M | $51.07M | $60.69M |
Total Liabilities | Not available | $36.32M | $9.65M | $14.64M | $16.23M |
Cash & Equivalents | Not available | $36.67M | $21.26M | $14.80M | $11.02M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 62.05M | 43.54M | 41.96M | 39.17M |